nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ESR1—uterine fibroid	0.913	1	CbGaD
Naloxone—TLR4—decidua—uterine fibroid	0.00599	0.0931	CbGeAlD
Naloxone—TLR4—endometrium—uterine fibroid	0.00568	0.0884	CbGeAlD
Naloxone—ESR1—oviduct—uterine fibroid	0.00437	0.068	CbGeAlD
Naloxone—TLR4—female gonad—uterine fibroid	0.00429	0.0666	CbGeAlD
Naloxone—CREB1—myometrium—uterine fibroid	0.00356	0.0553	CbGeAlD
Naloxone—CREB1—uterine cervix—uterine fibroid	0.00277	0.043	CbGeAlD
Naloxone—CREB1—smooth muscle tissue—uterine fibroid	0.00269	0.0418	CbGeAlD
Naloxone—CREB1—decidua—uterine fibroid	0.00264	0.041	CbGeAlD
Naloxone—CREB1—urethra—uterine fibroid	0.00254	0.0395	CbGeAlD
Naloxone—CREB1—endometrium—uterine fibroid	0.0025	0.0389	CbGeAlD
Naloxone—CREB1—mammalian vulva—uterine fibroid	0.00242	0.0376	CbGeAlD
Naloxone—CREB1—uterus—uterine fibroid	0.00231	0.0359	CbGeAlD
Naloxone—CREB1—female reproductive system—uterine fibroid	0.00207	0.0322	CbGeAlD
Naloxone—CREB1—female gonad—uterine fibroid	0.00189	0.0293	CbGeAlD
Naloxone—CREB1—vagina—uterine fibroid	0.00187	0.0292	CbGeAlD
Naloxone—OPRK1—female reproductive system—uterine fibroid	0.00157	0.0244	CbGeAlD
Naloxone—ESR1—myometrium—uterine fibroid	0.0014	0.0218	CbGeAlD
Naloxone—ESR1—uterine cervix—uterine fibroid	0.00109	0.0169	CbGeAlD
Naloxone—ESR1—smooth muscle tissue—uterine fibroid	0.00106	0.0165	CbGeAlD
Naloxone—ESR1—decidua—uterine fibroid	0.00104	0.0161	CbGeAlD
Naloxone—ESR1—endometrium—uterine fibroid	0.000985	0.0153	CbGeAlD
Naloxone—CREB1—Estrogen signaling pathway—ESR1—uterine fibroid	0.000981	0.0429	CbGpPWpGaD
Naloxone—ESR1—uterus—uterine fibroid	0.000908	0.0141	CbGeAlD
Naloxone—ESR1—female reproductive system—uterine fibroid	0.000816	0.0127	CbGeAlD
Naloxone—CYP2C8—endometrium—uterine fibroid	0.000811	0.0126	CbGeAlD
Naloxone—ESR1—Nuclear Receptors—PGR—uterine fibroid	0.000805	0.0352	CbGpPWpGaD
Naloxone—ESR1—Nuclear signaling by ERBB4—PGR—uterine fibroid	0.000789	0.0345	CbGpPWpGaD
Naloxone—ESR1—female gonad—uterine fibroid	0.000743	0.0115	CbGeAlD
Naloxone—ESR1—vagina—uterine fibroid	0.000738	0.0115	CbGeAlD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine fibroid	0.000701	0.0307	CbGpPWpGaD
Naloxone—CYP2C8—female reproductive system—uterine fibroid	0.000672	0.0105	CbGeAlD
Naloxone—ESR1—Nuclear Receptor transcription pathway—PGR—uterine fibroid	0.000637	0.0278	CbGpPWpGaD
Naloxone—CYP2C8—vagina—uterine fibroid	0.000608	0.00946	CbGeAlD
Naloxone—CREB1—LKB1 signaling events—ESR1—uterine fibroid	0.000595	0.026	CbGpPWpGaD
Naloxone—CREB1—PI-3K cascade—TNRC6B—uterine fibroid	0.000582	0.0255	CbGpPWpGaD
Naloxone—CREB1—PI3K/AKT activation—TNRC6B—uterine fibroid	0.000568	0.0248	CbGpPWpGaD
Naloxone—CREB1—GAB1 signalosome—TNRC6B—uterine fibroid	0.000564	0.0247	CbGpPWpGaD
Naloxone—ABCB1—myometrium—uterine fibroid	0.000553	0.0086	CbGeAlD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.000551	0.0241	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TNRC6B—uterine fibroid	0.000535	0.0234	CbGpPWpGaD
Naloxone—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine fibroid	0.000531	0.0232	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—ESR1—uterine fibroid	0.000462	0.0202	CbGpPWpGaD
Naloxone—CYP3A4—female reproductive system—uterine fibroid	0.000455	0.00708	CbGeAlD
Naloxone—CREB1—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000435	0.019	CbGpPWpGaD
Naloxone—ABCB1—uterine cervix—uterine fibroid	0.00043	0.00669	CbGeAlD
Naloxone—CREB1—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.000416	0.0182	CbGpPWpGaD
Naloxone—ABCB1—decidua—uterine fibroid	0.00041	0.00637	CbGeAlD
Naloxone—CREB1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00041	0.0179	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—PGR—uterine fibroid	0.000406	0.0177	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—TNRC6B—uterine fibroid	0.000404	0.0177	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—ESR1—uterine fibroid	0.000403	0.0176	CbGpPWpGaD
Naloxone—ABCB1—urethra—uterine fibroid	0.000395	0.00615	CbGeAlD
Naloxone—CREB1—Downstream signal transduction—TNRC6B—uterine fibroid	0.000391	0.0171	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—TNRC6B—uterine fibroid	0.000389	0.017	CbGpPWpGaD
Naloxone—ABCB1—endometrium—uterine fibroid	0.000389	0.00605	CbGeAlD
Naloxone—CREB1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000388	0.0169	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—TNRC6B—uterine fibroid	0.000386	0.0169	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—ESR1—uterine fibroid	0.000381	0.0167	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00038	0.0166	CbGpPWpGaD
Naloxone—ABCB1—mammalian vulva—uterine fibroid	0.000376	0.00585	CbGeAlD
Naloxone—CREB1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000363	0.0159	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—TNRC6B—uterine fibroid	0.000363	0.0159	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000363	0.0159	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00036	0.0157	CbGpPWpGaD
Naloxone—ABCB1—uterus—uterine fibroid	0.000359	0.00558	CbGeAlD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine fibroid	0.000358	0.0157	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000356	0.0156	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—TNRC6B—uterine fibroid	0.000355	0.0155	CbGpPWpGaD
Naloxone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000343	0.015	CbGpPWpGaD
Naloxone—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000338	0.0148	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—TNRC6B—uterine fibroid	0.000336	0.0147	CbGpPWpGaD
Naloxone—ABCB1—female reproductive system—uterine fibroid	0.000322	0.00501	CbGeAlD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000321	0.014	CbGpPWpGaD
Naloxone—ABCB1—female gonad—uterine fibroid	0.000293	0.00456	CbGeAlD
Naloxone—ABCB1—vagina—uterine fibroid	0.000291	0.00453	CbGeAlD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000278	0.0122	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000268	0.0117	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—PGR—uterine fibroid	0.000266	0.0116	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—TNRC6B—uterine fibroid	0.000247	0.0108	CbGpPWpGaD
Naloxone—TLR4—Immune System—TNRC6B—uterine fibroid	0.000235	0.0103	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000218	0.00952	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—ESR1—uterine fibroid	0.000217	0.00947	CbGpPWpGaD
Naloxone—CREB1—Disease—HPSE2—uterine fibroid	0.000211	0.00925	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MED12—uterine fibroid	0.000191	0.00834	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000184	0.00805	CbGpPWpGaD
Naloxone—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000182	0.00794	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00018	0.00789	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000149	0.00652	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000148	0.00646	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000146	0.00637	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—HPSE2—uterine fibroid	0.000143	0.00627	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—TNRC6B—uterine fibroid	0.000141	0.00616	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000138	0.00603	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000135	0.00592	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MED12—uterine fibroid	0.000133	0.0058	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000115	0.00505	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—PGR—uterine fibroid	0.00011	0.00481	CbGpPWpGaD
Naloxone—CREB1—Immune System—TNRC6B—uterine fibroid	8.21e-05	0.00359	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	7.93e-05	0.00347	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	7.82e-05	0.00342	CbGpPWpGaD
Naloxone—CREB1—Disease—TNRC6B—uterine fibroid	7.58e-05	0.00331	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HPSE2—uterine fibroid	7.05e-05	0.00308	CbGpPWpGaD
Naloxone—ALB—Metabolism—HPSE2—uterine fibroid	7e-05	0.00306	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	6.77e-05	0.00296	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	6.74e-05	0.00294	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MED12—uterine fibroid	6.39e-05	0.00279	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	6.25e-05	0.00273	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MED12—uterine fibroid	6.14e-05	0.00268	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HPSE2—uterine fibroid	6.14e-05	0.00268	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	5.67e-05	0.00248	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	5.64e-05	0.00247	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—TNRC6B—uterine fibroid	5.35e-05	0.00234	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TNRC6B—uterine fibroid	5.31e-05	0.00232	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—PGR—uterine fibroid	5.29e-05	0.00231	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TNRC6B—uterine fibroid	5.29e-05	0.00231	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PGR—uterine fibroid	5.25e-05	0.0023	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PGR—uterine fibroid	5.24e-05	0.00229	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP17A1—uterine fibroid	5.14e-05	0.00225	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TNRC6B—uterine fibroid	4.64e-05	0.00203	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PGR—uterine fibroid	4.59e-05	0.00201	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TNRC6B—uterine fibroid	3.92e-05	0.00171	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PGR—uterine fibroid	3.88e-05	0.0017	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HPSE2—uterine fibroid	3.78e-05	0.00165	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TNRC6B—uterine fibroid	3.48e-05	0.00152	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PGR—uterine fibroid	3.44e-05	0.0015	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MED12—uterine fibroid	3.02e-05	0.00132	CbGpPWpGaD
Naloxone—ALB—Metabolism—MED12—uterine fibroid	3e-05	0.00131	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ESR1—uterine fibroid	2.81e-05	0.00123	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ESR1—uterine fibroid	2.8e-05	0.00122	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MED12—uterine fibroid	2.63e-05	0.00115	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP17A1—uterine fibroid	2.53e-05	0.0011	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP17A1—uterine fibroid	2.51e-05	0.0011	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ESR1—uterine fibroid	2.45e-05	0.00107	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP17A1—uterine fibroid	2.2e-05	0.000962	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ESR1—uterine fibroid	2.07e-05	0.000906	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MED12—uterine fibroid	1.62e-05	0.000708	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP17A1—uterine fibroid	1.36e-05	0.000593	CbGpPWpGaD
